(Q38510741)

English

Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders.

scientific article published on June 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030725%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

6 references

Europe PubMed Central

23 July 2020

10 September 2020

2 November 2020

14 November 2020

19 November 2020

Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030725%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

genetic predisposition to disease

1 reference

23 July 2020

pharmacogenomics

1 reference

based on heuristic

inferred from title

1 reference

2 November 2020

precision medicine

1 reference

14 November 2020

genetic testing

1 reference

19 November 2020

author name string

Gregory P Hess

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030725%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Eileen Fonseca

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030725%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Rachel Scott

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030725%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Jesen Fagerness

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030725%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

1 June 2015

5 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030725%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

23 July 2020

2 November 2020

14 November 2020

19 November 2020

Genetics Research

5 references

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030725%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

23 July 2020

2 November 2020

14 November 2020

19 November 2020

97

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030725%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

e13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030725%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

copyright license

Creative Commons Attribution

4 references

23 July 2020

2 November 2020

14 November 2020

19 November 2020

copyright status

0 references

Prioritization and evaluation of depression candidate genes by combining multidimensional data resources

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Insurance coverage policies for personalized medicine

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

The STAR*D Project results: a comprehensive review of findings.

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

ACCF/AHA clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents and the American Heart Association endorsed by the Society for Ca

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Too much ado about propensity score models? Comparing methods of propensity score matching.

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Statin-associated myopathy

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Contribution of common genetic variants to antidepressant response

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Review of the cost effectiveness of pharmacogenetic-guided treatment of hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update.

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Towards the clinical implementation of pharmacogenetics in bipolar disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Should we be applying warfarin pharmacogenetics to clinical practice? No, not now.

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Pharmacogenomics--drug disposition, drug targets, and side effects

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Payer perspectives on pharmacogenomics testing and drug development.

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for ivacaftor therapy in the context of CFTR genotype

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Applying propensity score methods in medical research: pitfalls and prospects

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

How will GINA influence participation in pharmacogenomics research and clinical testing?

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Pharmacogenetics of antidepressant response

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Pharmacogenomics, evidence, and the role of payers

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Clinical and economic challenges facing pharmacogenomics

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

21 January 2018

Paying for outcomes: innovative coverage and reimbursement schemes for pharmaceuticals

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

7 January 2021

based on heuristic

inferred from DOI database lookup

Personalized medicine: factors influencing reimbursement.

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic testing insurance coverage trends: a review of publicly available policies from the largest US payers

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

7 January 2021

based on heuristic

inferred from DOI database lookup

Epigenetic techniques in pharmacogenetics

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical application of pharmacogenetics

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

7 January 2021

based on heuristic

inferred from DOI database lookup

Coverage options for promising technologies: Medicare's 'coverage with evidence development'

1 reference

https://api.crossref.org/works/10.1017%2FS0016672315000099

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacogenetics of Statin-Induced Myopathy: A Focused Review of the Clinical Translation of Pharmacokinetic Genetic Variants

1 reference

https://pubmed.ncbi.nlm.nih.gov/26030725

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Racial and ethnic differences in response to medicines: towards individualized pharmaceutical treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26030725

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment-resistant depression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26030725

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medicare program; revisions to payment policies under the Physician Fee Schedule, Clinical Laboratory Fee Schedule, access to identifiable data for the Center for Medicare and Medicaid Innovation Models & other revisions to Part B for CY 2015. Final

1 reference

https://pubmed.ncbi.nlm.nih.gov/26030725

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacogenetic-guided psychiatric intervention associated with increased adherence and cost savings.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26030725

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1017/S0016672315000099

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030725%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030725%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030725%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38510741&oldid=1516957193"